Patents by Inventor Dennis L. Sprecher

Dennis L. Sprecher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING HEREDITARY HEMORRHAGIC TELANGIECTASIA USING PAZOPANIB
    Publication number: 20240075031
    Abstract: The present disclosure provides methods of treating a subject with hereditary hemorrhagic telangiectasia using pazopanib, wherein the method includes identifying a hemorrhagic locus, determining a therapeutically effective amount of pazopanib as a function of the hemorrhagic locus, and administering the therapeutically effective amount of pazopanib to a subject for a period of at least 6 months. In addition, treatment is targeted to vascular densities throughout the body which drive hemodynamic compromise or cosmetic disfigurement. The present disclosure provides a method of ensconcing a powder form of a therapeutically effective amount of pazopanib in a housing compartment comprising a capsule and administering the housing compartment filed with the powder form of the therapeutically effective amount of pazopanib to the subject for a period of at least 6 months.
    Type: Application
    Filed: December 7, 2021
    Publication date: March 7, 2024
    Inventor: Dennis L. SPRECHER
  • NICOTINAMIDE DERIVATE IN THE TREATMENT OF ACUTE CORONARY SYNDROME
    Publication number: 20160367542
    Abstract: The use of a nicotinamide derivative in the treatment acute coronary syndrome (ACS) and pharmaceutical compositions used in such treatment.
    Type: Application
    Filed: September 2, 2016
    Publication date: December 22, 2016
    Inventors: Michele Ghirardi, David Greenhalgh, Dennis L. Sprecher, Robert Nicholas Willette
  • NICOTINAMIDE DERIVATE IN THE TREATMENT OF ACUTE CORONARY SYNDROME
    Publication number: 20150209337
    Abstract: The present invention relates to the use of a nicotinamide derivative in the treatment acute coronary syndrome (ACS) and pharmaceutical compositions used in such treatment.
    Type: Application
    Filed: July 9, 2013
    Publication date: July 30, 2015
    Inventors: Michele Ghirardi, David Greenhalgh, Dennis L. Sprecher, Robert Nicholas Willette